Clinical Therapeutics Journal

Overview
Identity
View All

publication venue for

LINEAR CHANGES IN STRENGTH AND SPIROMETRY IN TWO PATIENTS WITH ADULT-ONSET POMPE DISEASE SUPPLEMENTED WITH CREATINE MONOHYDRATE 2010
Decreased ventilator use in a 27-year-old man with late-onset Pompe disease within 1 year of using alglucosidase alfa 2008
Applying quality-of-life data formally and systematically into clinical practice 2003
What is the value added to the clinician of health-related quality-of-life information from clinical research and using QOL measures in clinical practice? 2003
Methods for explaining the clinical significance of health status measures 2002
Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China. 41:2308-2320.e11. 2019
Should Clinical Trials Be Terminated Early?. 41:1889-1891. 2019
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study. 40:1024-1032. 2018
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study. 40:415-429.e6. 2018
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis. 39:1780-1789.e33. 2017
Gap Between Official Guidelines and Clinical Practice for the Treatment of Rheumatoid Arthritis in São Paulo, Brazil. 38:1122-1133. 2016
Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014. 37:2506-2514.e4. 2015
Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis. 37:225-241.e8. 2015
Onset of Response with Duloxetine Treatment in Patients with Osteoarthritis Knee Pain and Chronic Low Back Pain: A Post Hoc Analysis of Placebo-Controlled Trials. 36:544-551. 2014
Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline. 35:1282-1303. 2013
Targeting the Unstable Plaque in Acute Coronary Syndromes. 35:1099-1107. 2013
Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. 32:844-860. 2010
Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study. 31:1747-1753. 2009
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura. 31:1082-1091. 2009
A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins. 31:679-691. 2009
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study. 29:2055-2067. 2007
Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study. 29:1390-1402. 2007
A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets. 29:519-528. 2007
Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial. 29:419-426. 2007
Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial. 29:419-426. 2007
A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). 29:305-315. 2007
Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. 29:230-241. 2007
Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.. 29:230-241. 2007
Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective. 28:1922-1934. 2006
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment. 26:15-28. 2004
Quality of life III: Translating the science of quality-of-life assessment into clinical practice—an example-driven approach for practicing clinicians and clinical researchers. 25:D1-D5. 2003
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: A randomized, open-label, multicenter study of clinical efficacy and tolerability. 24:1915-1936. 2002
A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. 24:639-652. 2002
Assessing the clinical significance of quality-of-life measures in oncology research: State of the science. 24:1-4. 2002
Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective. 23:2038-2049. 2001
Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness. 23:1492-1507. 2001
Comparison of topical nedocromil sodium and oral terfenadine for the treatment of seasonal allergic conjunctivitis. 21:1900-1907. 1999
The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion. 19:1013-1023. 1997
C18. Testing the constant proportional trade-off assumption using standard gamble. 18:31-32. 1996
C19. Quality-adjusted life-years and healthy years equivalent: an empiric comparison. 18:32. 1996
A POSTMARKETING SURVEILLANCE EVALUATION OF QUINAPRIL IN 3742 CANADIAN HYPERTENSIVE PATIENTS - THE ACCEPT STUDY. 16:838-853. 1994
A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.. 16:838-853. 1994
Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.. 16:505-521. 1994
Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.. 14:276-291. 1992

has subject area

1115 Pharmacology and Pharmaceutical Sciences (FoR)
Optoelectronics & Photonics (Science Metrix)